Complete report is spread across 49 pages is available @ http://www.reportsnreports.com/reports/279551-epicast-report-ankylosing-spondylitis-epidemiology-forecast-to-2022.html .
Ankylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, and is one of the most common rheumatic conditions throughout the world. Ankylosing spondylitis primarily affects the spine and sacroiliac joints, with involvement with other joints in the shoulders, hips, and knees. It can progress into severe inflammation that fuses the spine, leading to permanent painful stiffness of the back. Although treatment helps in relieving pain and stiffness and keeps the spine flexible, the disease is irreversible and people with the disorder have to cope with symptoms throughout their lives. Global prevalence of the disease ranges from 0.01%–1.40%, with higher prevalence in western European Caucasian populations. The epidemiology of ankylosing spondylitis follows a specific geographic distribution mirroring the global variation in prevalence of the HLA-B27 risk allele.
Researcher epidemiologists forecast an increase in the diagnosed prevalent cases of ankylosing spondylitis in the 7MM from 818,456 diagnosed prevalent cases in 2012 to 850,849 diagnosed prevalent cases in 2022, with an annual growth rate (AGR) of 0.40%. Throughout the forecast period, the US will have the highest number of diagnosed prevalent cases of ankylosing spondylitis, with 608,813 diagnosed prevalent cases in 2022.
In this analysis, Researcher epidemiologists provided detailed, clinically relevant segmentations for diagnosed ankylosing spondylitis cases. To forecast the diagnosed prevalent cases, Researcher epidemiologists used country-specific estimates from peer-reviewed journal articles in which ankylosing spondylitis was diagnosed using valid diagnostic criteria and radiographic evidence. Another strength of this analysis is that the same methodology was used across the 7MM, thereby allowing for meaningful global comparisons of the diagnosed prevalent cases of ankylosing spondylitis.
